NINJ2 and cancer: By measuring tumor volumes, we show that the xenografts-derived from NINJ2 knockout primary cancer cells (“KO-NINJ2”) grew significantly slower than the xenografts of control cancer cells (“Ctrl”) (Figure 7A).